Design, synthesis and antibacterial evaluation of 2,4-disubstituted-6-thiophenyl-pyrimidines

Add time:07/23/2019    Source:sciencedirect.com

The increasing incidences of multidrug resistant bacterial infections urge the development of novel antibacterial having a new mechanism of action. The small molecule-based inhibitors targeting at the cell division protein FtsZ has been recognized as a promising approach to search for new antibacterial with high potency. In the present study, a series of novel 2,4-disubstituted-6-thiophenyl-pyrimidine derivatives were synthesized and their antibacterial activities against clinically related pathogens were investigated. The compounds show strong antibacterial activities against MRSA and VREs. The antibacterial activity of compound Bb2 against MRSA and VREs (MIC values: 2 μg/mL) is stronger than that of methicillin and vancomycin. From the in vitro and in vivo results, Bb2 was found to inhibit GTPase activity and FtsZ polymerization. The compound is able to inhibit bacterial cell division through interacting with GTP binding site of FtsZ and thus causing cell death. In addition, S. aureus was found to develop resistance to methicillin but not for Bb2, which was proved in our resistance generation experiments.

We also recommend Trading Suppliers and Manufacturers of 6-AMINO-1-(3-(TRIFLUOROMETHYL)PHENYL)PYRIMIDINE-2,4(1H,3H)-DIONE (cas 19136-40-4). Pls Click Website Link as below: cas 19136-40-4 suppliers

Prev:In vivo pharmacological characterization of (±)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand: microdialysis studies
Next:Synthesis, photoluminescence and electroluminescence of one iridium complex with 2-(2,4-difluorophenyl)-4-(trifluoromethyl)pyrimidine and tetraphenylimidodiphosphinate ligands)